Raaj medisafe India Limited has announced that its Board of Directors will convene on February 11, 2026, at 3:00 PM to deliberate on the company's third quarter financial performance and other statutory matters. The meeting will take place at the company's registered office located at 75/2 & 3, Industrial Area, Maksi Road, Ujjain-456010.

Key Agenda Items

The board meeting will address several critical business matters for the quarter ended December 31, 2025:

Regulatory Compliance Matters

The board will take on record several quarterly compliance reports submitted to BSE:

• Statement of investor complaints
• Shareholding pattern report
• Integrated governance report
• Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

Meeting Structure

The meeting agenda includes provisions for additional items to be considered with the Chairman's permission and majority director consent, including at least one Independent Director if present. The company has notified BSE Limited about this scheduled meeting in compliance with regulatory requirements.

Company Information

Raaj Medisafe India Limited, with scrip code 524502 on BSE, operates from its registered office in Ujjain's industrial area. The meeting notice was signed by Chairman and Managing Director Arpit Bangur (DIN: 02600716) on February 2, 2026.

Raaj medisafe India Limited successfully conducted its Extra Ordinary General Meeting on January 20, 2026, through video conferencing, addressing crucial capital structure decisions and corporate governance matters. The meeting commenced at 4:00 PM and concluded at 4:27 PM, with e-voting extending until 4:42 PM.

Meeting Structure and Governance

The EGM maintained proper regulatory compliance with requisite quorum present as per the Companies Act, 2013 provisions. The Chairman declared the meeting in order and appointed Mr. Manish Maheshwari as scrutinizer for both remote e-voting and e-voting during the meeting. The agenda items were based on the notice dated December 23, 2025, convening the Extra Ordinary General Meeting.

Key Resolutions Approved

The meeting addressed three significant business items that will impact the company's capital structure and operational flexibility:

Equity Share Issuance Details

The company approved the issuance of 32,75,000 equity shares of ₹10.00 face value each for cash at a premium of ₹45.00 per share through preferential allotment. This preferential allotment targets a select group of non-promoter persons, representing a significant capital raising initiative.

Shareholder Engagement and Communication

The Chairman facilitated shareholder participation by inviting speakers and addressing queries received from shareholders. The company emphasized its commitment to transparent communication by requesting shareholders to submit additional queries through the official email provided on the company website for comprehensive responses.

Next Steps and Documentation

The company indicated that detailed results of remote e-voting and e-voting conducted during the EGM will be forwarded separately upon declaration. This follows standard corporate governance practices for maintaining transparency in shareholder voting processes and ensuring proper documentation of meeting outcomes.